BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Döring JH, Schröter J, Jüngling J, Biskup S, Klotz KA, Bast T, Dietel T, Korenke GC, Christoph S, Brennenstuhl H, Rubboli G, Møller RS, Lesca G, Chaix Y, Kölker S, Hoffmann GF, Lemke JR, Syrbe S. Refining Genotypes and Phenotypes in KCNA2-Related Neurological Disorders. Int J Mol Sci 2021;22:2824. [PMID: 33802230 DOI: 10.3390/ijms22062824] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Feng T. Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach. Biochem Genet. [DOI: 10.1007/s10528-022-10280-x] [Reference Citation Analysis]
2 Dinoi G, Morin M, Conte E, Mor Shaked H, Coppola MA, D’adamo MC, Elpeleg O, Liantonio A, Hartmann I, De Luca A, Blunck R, Russo A, Imbrici P. Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia. IJMS 2022;23:8079. [DOI: 10.3390/ijms23158079] [Reference Citation Analysis]
3 Nilsson M, Lindström SH, Kaneko M, Wang K, Minguez-Viñas T, Angelini M, Steccanella F, Holder D, Ottolia M, Olcese R, Pantazis A. An epilepsy-associated KV1.2 charge-transfer-center mutation impairs KV1.2 and KV1.4 trafficking. Proc Natl Acad Sci U S A 2022;119:e2113675119. [PMID: 35439054 DOI: 10.1073/pnas.2113675119] [Reference Citation Analysis]
4 Levy AM, Gomez-Puertas P, Tümer Z. Neurodevelopmental Disorders Associated with PSD-95 and Its Interaction Partners. Int J Mol Sci 2022;23:4390. [PMID: 35457207 DOI: 10.3390/ijms23084390] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Absalom NL, Liao VWY, Johannesen KMH, Gardella E, Jacobs J, Lesca G, Gokce-Samar Z, Arzimanoglou A, Zeidler S, Striano P, Meyer P, Benkel-Herrenbrueck I, Mero IL, Rummel J, Chebib M, Møller RS, Ahring PK. Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies. Nat Commun 2022;13:1822. [PMID: 35383156 DOI: 10.1038/s41467-022-29280-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Perilli L, Mastromoro G, Murciano M, Amedeo I, Avenoso F, Pizzuti A, Guido CA, Spalice A. Myoclonic Epilepsy: Case Report of a Mild Phenotype in a Pediatric Patient Expanding Clinical Spectrum of KCNA2 Pathogenic Variants. Front Neurol 2021;12:806516. [PMID: 35178022 DOI: 10.3389/fneur.2021.806516] [Reference Citation Analysis]
7 Xiong J, Liu Z, Chen S, Kessi M, Chen B, Duan H, Deng X, Yang L, Peng J, Yin F. Correlation Analyses of Clinical Manifestations and Variant Effects in KCNB1-Related Neurodevelopmental Disorder. Front Pediatr 2021;9:755344. [PMID: 35071126 DOI: 10.3389/fped.2021.755344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Imbrici P, Conte E, Blunck R, Stregapede F, Liantonio A, Tosi M, D'Adamo MC, De Luca A, Brankovic V, Zanni G. A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine. Int J Mol Sci 2021;22:9913. [PMID: 34576077 DOI: 10.3390/ijms22189913] [Cited by in F6Publishing: 2] [Reference Citation Analysis]